Synovial Sarcoma, X Breakpoint

Synovial Sarcoma, X Breakpoint

Name

Description

Product #

Price

Quantity

Shipping Method

  • View Data Sheet

    Description:

    Synovial Sarcoma, X Breakpoint 2 Human Recombinant

    Cancer/testis antigen family 5, member 2b, CT5.2b, Protein SSX2, Cancer/testis antigen 5.2, Synovial sarcoma, X breakpoint 2, CT5.2, Tumor antigen HOM-MEL-40, SSX2, SSX2A, SSX2B.

    Product # :

    PRO-1996

    Price :

    Quantity :

    Shipping Method :

    Ice Icon

    Shipped with Ice Packs

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 85.0% as determined by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    • Amino Acid Sequence
    Ssx2 Human
  • View Data Sheet

    Description:

    Synovial Sarcoma, X Breakpoint 1 Human Recombinant

    Synovial Sarcoma X Breakpoint 1, Cancer/Testis Antigen 5.1, CT5.1, SSRC Sarcoma Synovial X-Chromosome-Related 1, Cancer/Testis Antigen Family 5 Member 1, Cancer/Testis Antigen Family 5, Protein SSX1, Member 1, SSX1.

    Product # :

    PRO-1379

    Price :

    Quantity :

    Shipping Method :

    Ice Icon

    Shipped with Ice Packs

    Add To Cart

    More Info

    • purity
    • More Info

    Purity

    Greater than 85.0% as determined by SDS-PAGE.

    More Info

    • Introduction
    • Synonyms
    • Physical Appearance
    • Stability
    • Amino Acid Sequence
    Ssx1 Human

About SSX / Synovial Sarcoma, X Breakpoint:

Synovial sarcoma is a rare type of cancer that occurs in the joints, muscles and other soft tissues. It is characterized by an abnormal growth of immature cells in the lining of the joint cavity called synovium. The main characteristic that distinguishes synovium from other types of cancers is its location inside a joint where it replaces normal tissue. Synovial sarcoma can be divided into two categories: high-grade (aggressive) or low-grade (slow-growing). There are currently no screening tests for synovial sarcoma, but treatment options are available to help control this condition.

SSX Function
The X Breakpoint or GC SSX2 gene causes Synovial Sarcoma at least 5% of the time and is prevalent in young people aged 12-30 years old. This gene causes cells to divide more rapidly than usual, which leads to an abnormal accumulation of cells within a joint or muscle. It can also make the surrounding area inflamed, causing pain.

Synovial Sarcoma, X Breakpoint Mechanism
Like other cancers caused by genetic changes, this condition starts when something goes wrong with the DNA inside cells’ nucleus that makes them not function properly anymore; these mistakes are called mutations, and they affect genes on chromosomes 17 and 22 as well as chromosome X in men (women have two copies of each X chromosome). The resulting imbalance deregulates cell growth leading it to grow abnormally fast out of control, ultimately causing cancerous tumors to grow throughout soft tissues. These mutations occur randomly and are not inherited but can be passed on to other generations if a mutation is found in the germline cells (egg or sperm).